AFP, DCP, p53, PCNA, EZ2H, as well as other tissue markers proposed by some researchers, have a certain role in the diagnosis of HCC but are of limited use in suggesting the presence of precancerous lesions, especially in the differentiation of precancerous lesions from HCC. This evidence concerns the gene ACE and hepatocellular carcinoma.